Document is current

Article History

Received: 21 June 2024

Revised: 21 June 2024

Accepted: 5 August 2024

First Online: 30 August 2024

Declarations

:

: Dr. Simpson reports personal fees from AbbVie, Amgen, Arena Pharmaceuticals, Aslan Pharma, Boston Consulting Group, Collective Acumen, LLC (CA), Dermira, Eli Lilly, Evidera, Excerpta Medica, Forte Bio RX, Galderma, GlaxoSmithKline, Incyte, Janssen, Kyowa Kirin Pharmaceutical Development, Leo Pharma, Medscape LLC, Pfizer, Physicians World LLC, Regeneron, Sanofi-Genzyme, Trevi Therapeutics, and WebMD and grants (or Principal Investigator role) from AbbVie, Amgen, Arcutis, Aslan, CorEvitas, Dermavant, Dermira, Eli Lilly, Incyte, Kymab, Kyowa Hakko Kirin, Leo Pharma, Merck, Novartis, Pfizer, Regeneron, Sanofi, and TARGET-DERM. These potential conflicts of interest have been reviewed and managed by OHSU. Dr. Guttman-Yassky reports consultant fees from AbbVie, Almirall, Amgen, Arena Pharmaceuticals, Asana Biosciences, AstraZeneca, Bluefin Biomedicine, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol Meyers Squibb, Cara Therapeutics, Celgene, Connect Biopharma, DBV, DS Biopharma, Eli Lilly, EMD Serono, Evidera, Galderma, Ichnos Sciences (Glenmark), Incyte, Janssen, Kyowa, Kirin, Leo Pharma, Novartis, Pandion Therapeutics, Pfizer, Principa, RAPT Therapeutics, Regeneron, Sanofi, SATO, Siolta Therapeutics, Target Pharma Solutions, UCB, Union Therapeutics, and Ventyx; serves as an investigator for AbbVie, AstraZeneca, Eli Lilly, Kyowa Kirin, Leo Pharma, Pfizer, and Regeneron; serves on advisory boards for AbbVie, Aditum Bio, Aena Pharmaceuticals, Asana Biosciences, AstraZeneca, Bluefin Biomedicine, Boehringer Ingelheim, Bristol Meyers Squibb, Cara Therapeutics, Connect Biopharma, DBV, Eli Lilly, Galderma, Ichnos Sciences (Glenmark), Incyte, Janssen, Kyowa Kirin, Leo Pharma, Novartis, Pfizer, RAPT Therapeutics (Flx Bio), Regeneron, Sanofi, Union Therapeutics, SATO, Siolta Therapeutics, Target Pharma Solutions, and Ventyx; received grants from Almirall, Amgen, AnaptysBio, Asana Bioscience, AstraZeneca, Bristol Meyers Squibb, Cara Therapeutics, DS Biopharma, Galderma, Innovaderm, Janssen, KAO, Kiniska, Kyowa Kirin, Leo Pharma, Pfizer, Regeneron, and UCB; and is a stockholder with RAPT. Dr. Pawlikowski is an employee of Janssen Pharmaceutical Companies of Johnson & Johnson. Dr. Ghorayeb is an employee of Janssen Pharmaceutical Companies of Johnson & Johnson. Dr. Ota is an employee of Janssen Research & Development, LLC. Dr. Lebwohl is an employee of Mount Sinai and reports research funds from Abbvie, Amgen, Arcutis, Avotres, Boehringer Ingelheim, Cara Therapeutics, Dermavant Sciences, Eli Lilly, Incyte, Inozyme, Janssen Research & Development, LLC, Ortho Dermatologics, Pfizer, Sanofi-Regeneron, and UCB, Inc., and reports consultant fees from Almirall, AltruBio Inc., AnaptysBio, Apogee, Arcutis, Inc., AstraZeneca, Atomwise, Avotres Therapeutics, Brickell Biotech, Boehringer Ingelheim, Bristol Myers Squibb, Castle Biosciences, Celltrion, CorEvitas, Dermavant Sciences, EPI, Evommune, Inc., Facilitation of International Dermatology Education, Forte Biosciences, Foundation for Research and Education in Dermatology, Galderma, Genentech, Incyte, LEO Pharma, Meiji Seika Pharma, Mindera, Pfizer, Sanofi-Regeneron, Seanergy, Strata, Takeda, Trevi, and Verrica.

: All human studies were approved by the respective authors’ Institutional Review Boards (IRBs), and the studies’ protocols and amendments were reviewed by an Independent Ethics Committee or IRB. The studies were performed in accordance with the Declaration of Helsinki (64th World Medical Association General Assembly, Fortaleza, Brazil, October 2013), and conducted in compliance with the International Conference on Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines on Good Clinical Practice. The studies were approved by the appropriate institutional review board or local ethics committee as listed in the Supplementary Material.

: Written informed consent was obtained from all individual participants included in each study.